CastleArk Alternatives’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-52,908	Closed	-$3.14M	–	111
2021 Q3	$3.14M	Buy	+52,908	New	+$3.14M	0.12%	160